53
Growth Score
pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
326517
Nalo Therapeutics is a biotech company that develops pharmaceutical products intended to treat hematological and solid tumors.
- Keith Wilson: Founder, President, and Chief Scientific OfficerPast Role: Oxford BioTherapeutics, Chief Scientific Officer
About the Company
Nalo Therapeutics is a biotech company that develops pharmaceutical products intended to treat hematological and solid tumors. Its products are small molecule-based medicines for the treatment of cancer, enabling customers to purchase medicines to treat cancer cells that originate from uncontrolled cellular growth.
The company was founded in 2017
and is based in New Castle, Delaware.
